MYLAN 143 MYLAN 143 (Indomethacin 25 mg)
Pill imprint MYLAN 143 MYLAN 143 has been identified as Indomethacin 25 mg.
Indomethacin is used in the treatment of gout, acute; back pain; cluster headaches; ankylosing spondylitis; pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 25 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 25 mg
- 14.00 mm
- Prescription only
D - Positive evidence of risk - starting at 30 weeks gestation
FD&C Green No. 3
sodium lauryl sulfate
sodium starch glycolate type A potato
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|51079-0190||UDL Laboratories Inc|
|54569-0277||A-S Medication Solutions, LLC (repackager)|
|66267-0119||Nucare Pharmaceuticals Inc (repackager)|
|54569-4123||A-S Medication Solutions, LLC (repackager)|
|21695-0522||Rebel Distributors Corp (repackager)|
|23490-5755||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about indomethacin
- Indomethacin capsules
- Indomethacin suppositories
- Indomethacin suspension
- Indomethacin sustained-release capsules
- More (3) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.